Philipp du Cros

Eng koʻp iqtibos qilingan asarlar

1. Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011201315 iqtibos
2. A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis20228 iqtibos
3. Where there is hope: a qualitative study examining patients’ adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan20164 iqtibos
4. Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses20174 iqtibos
5. Risk Factors Associated with Default from Multi- and Extensively Drug-Resistant Tuberculosis Treatment, Uzbekistan: A Retrospective Cohort Analysis20134 iqtibos
6. Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan20163 iqtibos
7. ‘They prefer hidden treatment': anti-tuberculosis drug-taking practices and drug regulation in Karakalpakstan20162 iqtibos
8. Revised Definitions of Multidrug-Resistant Tuberculosis Treatment Outcomes: Closer to the Reality?20151 iqtibos
9. Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan20181 iqtibos
10. Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis20191 iqtibos

Hammualliflar

1. Nargiza Parpieva9 ta umumiy asar2015–2022
2. Atadjan Khamraev8 ta umumiy asar2015–2020
3. Zinaida Tigay6 ta umumiy asar2015–2022
4. Jay Achar5 ta umumiy asarSkelet yozuvlar: 12014–2020
5. Mathieu Bastard5 ta umumiy asar2013–2018
6. Kamene Kimenye5 ta umumiy asar2013–2018
7. Shazina Khurkhumal5 ta umumiy asar2013–2018
8. Արմեն Հայրապետյան5 ta umumiy asar2013–2018
9. Alex Telnov5 ta umumiy asar2013–2018
10. Francis Varaine5 ta umumiy asar2013–2018

Barcha hammualliflar →